Interleukin-1 Family [IL-1F1, F2]

The Cytokine Handbook

Volumn , Issue , 2003, Pages 643-668

  Dinarello, Charles A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942872625     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012689663-3/50031-4     Document Type: Chapter

References (186)

1. Abbondanzo S.J., Cullinan E.B., McIntyre K., et al. Reproduction in mice lacking a functional type 1 IL-1 receptor. Endocrinology 1996, 137:3598-3601.
2. Adachi O., Kawai T., Takeda K., et al. Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 1998, 9:143-150.
3. Alcami A., Smith G.L. A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 1992, 71:153-167.
4. Alheim K., Chai Z., Fantuzzi G., et al. Hyperresponsive febrile reactions to interleukin (IL) 1α and IL-1β, and altered brain cytokine mRNA and serum cytokine levels, in IL-1β-deficient mice. Proc. Natl Acad. Sci. USA 1997, 94:2681-2686.
5. Andersson J., Björk L., Dinarello C.A., et al. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur. J. Immunol. 1992, 22:2617-2623.
6. Andrieu N., Salvayre R., Levade T. Evidence against involvement of the acid lysosomal shingomyelinase in the tumor necrosis factor and interleukin-1-induced sphigomyelin cycle and cell proliferation in human fibroblasts. Biochem. J. 1994, 303:341-345.
7. Arend W.P., Malyak M., Smith M.F., et al. Binding of IL-1α, IL-1β, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J. Immunol. 1994, 153:4766-4774.
8. Auron P.E., Webb A.C. Interleukin-1: a gene expression system regulated at multiple levels. Eur. Cytokine Netw. 1994, 5:573-592.
9. Auron P.E., Webb A.C., Rosenwasser L.J., et al. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc. Natl Acad. Sci. USA 1984, 81:7907-7911.
10. Barton J.L., Herbst R., Bosisio D., et al. A tissue specific IL-1 receptor antagonist homolog from the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities. Eur. J. Immunol. 2000, 30:3299-3308.
11. Bernstein S.H., Fay J., Frankel S., et al. A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia. Cancer Chemother. Pharmacol. 1999, 43:141-144.
12. Beutler B. Autoimmunity and apoptosis. the Crohn's connection. Immunity 2001, 15:5-14.
13. Bird T.a., Gearing A.J., Saklatvala J. Murine interleukin-1 receptor: differences in binding properties between fibroblastic and thymoma cells and evidence for a two-chain receptor model. FEBS Lett. 1987, 225:21-26.
14. Bird T.a., Sleath P.R., de Roos P.C., et al. Interleukin-1 represents a new modality for the activation of extracellular signal-related kinases/microtubule-associated protein-2 kinases. J. Biol Chem. 1991, 266:22661-22670.
15. Bomalaski J.S., Steiner M.R., Simon P.L., Clark M.A. IL-1 increases phospholipase A2 activity, expression of phospholipase A2-activating protein, and release of linoleic acid from the murine T helper cell line EL-4. J. Immunol. 1992, 148:155-160.
16. Born T.L., Thomassen E., Bird T.A., Sins J.E. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. 1998, 273:29445-29450.
17. Boutin H., LeFeuvre R.A., Horai R., et al. Role of IL-1α and IL-1β in ischemic brain damage. J. Neurosci. 2001, 21:5528-5534.
18. Breder C.D., Dinarello C.A., Saper C.B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 1988, 240:321-324.
19. Bresnihan B., Alvaro-Gracia J.M., Cobby M., et al. Treatment of rheuatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998, 41:2196-2204.
20. Bresnihan B., Newmark R.D., Robbins S., et al. Anakinra reduces the rate of joint destruction after 1 year of treatment in a randomized controlled cohort of patients with rheumatoid arthritis. Arthritis Rheum. 2000, 43(Suppl. 9):S289.
21. Bristulf J., Gatti S., Malinowsky D., et al. Interleukin-1 stimulates the expression of type I and type II interleukin-1 receptors in the rat insulinoma cell line Rinm5F; sequencing a rat type II interleukin-1 receptor cDNA. Eur. Cyokine Netw. 1994, 5:319-330.
22. Brody D.T., Durum S.K. Membrane IL-1: IL-1α precursor binds to the plasma membrane via a lectin-like interaction. J. Immunol. 1989, 143:1183.
23. Buell G., Chessell I.P., Michel A.D., et al. Blockade of human P2X7 receptor function with a monoclonal antibody. Blood 1998, 92:3521-3528.
24. Busfield S.J., Comrack C.A., Yu G., et al. Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. Genomics 2000, 66:213-216.
25. Cao Z. Signal transduction of interleukin-1. Eur. Cytokine Netw. 1998, 9:378. (Abstr.).
26. Cao Z., Xiong J., Takeuchi M., et al. Interleukin-1 receptor activating kinase. Nature 1996, 383:443-446.
27. Carrie A., Jun L., Bienvenu T., et al. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat. Genet. 1999, 23:25-31.
28. Casadio R., Frigimelica E., Bossu P., et al. Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1β/IL-1R(I) complex. FEBS Lett. 2001, 499:65-68.
29. Chizzonite R., Truitt T., Kilian P.L., et al. Two high-affinity interleukin 1 receptors represent separate gene products. Proc. Natl Sci. USA 1989, 86:8029-8033.
30. Coeshott C., Ohnemus C., Pilyavskaya A., et al. Converting enzyme-independent release of TNFα and IL-1β from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase-3. Proc. Natl Sci. USA 1999, 96:6261-6266.
31. Colotta F., Re F., Muzio M., et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993, 261:472-475.
32. Colotta F., Dower S.K., Sims J.E., Mantovani A. The type II 'decoy' receptor: a novel regulatory pathway for interleukin-1. Immunol. Today 1994, 15:562-566.
33. Croston G.E., Cao Z., Goeddel D.V. NFkB activation by interleukin-1 requires an IL-1 receptor-associated protein kinase activity. J. Biol. Chem. 1995, 270:16514-16517.
34. Crown J., Jakubowski A., Kemeny N., et al. A phase I trial of recombinant human interleukin-1β alone and in combination with myelosuppressive doses of 5-fluoruracil in patients with gastrointestinal cancer. Blood 1991, 78:1420-1427.
35. Cuenda A., Rouse J., Doza Y.N., et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by stresses and interleukin-1. FEBS Lett. 1995, 364:229-233.
36. Cullinan E.B., Kwee L., Nunes P., et al. IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J. Immunol. 1998, 161:5614-5620.
37. Cunnane G., Madigan A., Murphy E., et al. The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis. Rheumatology (Oxford) 2001, 40:62-69.
38. Debets R., Timans J.C., Homey B., et al. Two novel IL-1 family members, IL-1 δ and IL-1 ε, function as an antagonist and agonist of NFκ β activation through the orphan IL-1 receptor-related protein 2. J. Immunol. 2001, 167:1440-1446.
39. DiDonato J.A., Hayakawa M., Rothwarf D.M., et al. A cytokine-responsive I κβ kinase that activates the transcription factor NFκβ. Nature 1997, 388:548-554.
40. Dinarello C.A. Biological basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
41. Dinarello C.A., Cannon J.G., Wolff S.M., et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med. 1986, 163:1433-1450.
42. Dower S.K., Fanslow W., Jacobs C., et al. Interleukin-1 antagonists. Ther. Immunol. 1994, 1:113-122.
43. Drevlow B.E., Lovis R., Haag M.A., et al. Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis. Arthritis Rheum. 1996, 39:257-265.
44. Evans R.J., Bray J., Childs J.D., et al. Mapping receptor binding sites in the IL-1 receptor antagonist and IL-1β by site-directed mutagenesis: identification of a single site in IL-1rα and two sites in IL-1β. J. Biol. Chem. 1994, 270:11477-11483.
45. Faggioni R., Fantuzzi G., Fuller J., et al. IL-1β mediates leptin induction during inflammation. Am. J. Physiol. 1998, 274:R204-R208.
46. Fanslow W.C., Sims J.E., Sassenfeld H., et al. Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor. Science 1990, 248:739-742.
47. Fantuzzi G., Ku G., Harding M.W., et al. Response to local inflammation of IL-1β converting enzyme-deficient mice. J. Immunol. 1997, 158:1818-1824.
48. Fantuzzi G., Sacco S., Ghezzi P., Dinarello C.A. Physiological and cytokine responses in interleukin-1β-deficient mice after zymosan-induced inflammation. Am. J. Physiol. 1997, 273:R400-R406.
49. Fantuzzi G., Zheng H., Faggioni R., et al. Effect of endotoxin in IL-1β-deficient mice. J. Immunol. 1996, 157:291-296.
50. Fantuzzi G., Reed D.A., Dinarello C.A. IL-12-induced IFNg is dependent on caspase-1 processing of the IL-18 precursor. J. Clin. Invest. 1999, 104:761-767.
51. Fenton M.J., Clark B.D., Collins K.L., et al. Transcriptional regulation of the human prointerleukin 1 β gene. J. Immunol. 1987, 138:3972-3979.
52. Fenton M.J., Vermeulen M.W., Clark B.D., et al. Human pro-IL-1 β gene expression in monocytic cells is regulated by two distinct pathways. J. Immunol. 1988, 140:2267-2273.
53. Fenton M.J., Lodie T., Buras J. NFbA is identical to the ETS family member PU.1 and is structurally altered following LPS activation. Cytokine 1994, 6:558.
54. Ferrari D., Chiozzi P., Falzoni S., et al. Extracellular ATP triggers IL-1 β release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 1997, 159:1451-1458.
55. Finch A., Holland P., Cooper J., Saklatvala J., Kracht M. Selective activation of JNK/SAPK by interleukin-1 in rabbit liver is mediated by MKK7. FEBS Lett. 1997, 418:144-148.
56. Freshney N.W., Rawlinson L., Guesdon F., et al. Interleukin-1 activates a novel protein cascade that results in the phosphorylation of hsp27. Cell 1994, 78:1039-1049.
57. Galcheva-Gargova Z., Dérijard B., Wu I.-H., Davis R.J. An osmosensing signal transduction pathway in mammalian cells. Science 1994, 265:806-809.
58. Gallis B., Prickett K.S., Jackson J., et al. IL-1 induces rapid phosphorylation of the IL-1 receptor. J. Immunol. 1989, 143:3235-3240.
59. Gay N.J., Keith F.J. Drosophila Toll and IL-1 receptor. Nature 1991, 351:355-356.
60. Gayle M.A., Slack J.L., Bonnert T.P., et al. Cloning of a putative ligand for the T1/ST2 receptor. J. Biol. Chem. 1996, 271:5784-5789.
61. Ghiara P., Armellini D., Scapigliati G., et al. Biological role of the IL-1 receptor type II as defined by a monoclonal antibody. Cytokine 1991, 3:473. (Abstr.).
62. Granowitz E.V., Porat R., Mier J.W., et al. Hematological and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans. Blood 1993, 82:2985-2990.
63. Greenfeder S.A., Nunes P., Kwee L., et al. Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J. Biol. Chem. 1995, 270:13757-13765.
64. Gronich J., Konieczkowski M., Gelb M.H., et al. Interleukin-1α causes a rapid activation of cytosolic phospholipase A2 by phosphorylation in rat mesangial cells. J. Clin. Invest. 1994, 93:1224-1233.
65. Gu Y., Wu J., Faucheu C., et al. Interleukin-1β converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J. 1995, 14:1923-1931.
66. Guida S., Heguy A., Melli M. The chicken IL-1 receptor: differential evolution of the cytoplasmic and extracellular domains. Gene 1992, 111:239-243.
67. Hammerberg C., Arend W.P., Fisher G.J., et al. Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J. Clin. Invest. 1992, 90:571-583.
68. Han J., Lee J.-D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994, 265:808-811.
69. Han J., Richter B., Li Z., et al. Molecular cloning of human p38 MAP kinase. Biochim. Biophys. Acta 1995, 1265:224-227.
70. Heguy A., Baldari C.T., Macchia G., et al. Amino acids conserved in interleukin-1 receptors and the Drosophila Toll protein are essential for IL-1R signal transduction. J. Biol. Chem. 1992, 267:2605-2609.
71. Hirsch E., Irikura V.M., Paul S.M., Hirsh D. Functions of interleukin-1 receptor antagonist in gene knockout and overproducing mice. Proc. Natl Acad. Sci. USA 1996, 93:11008-11013.
72. Hopp T.P. Evidence from sequence information that the interleukin-1 receptor is a transmembrane GTPase. Prot. Sci. 1995, 4:1851-1859.
73. Horai R., Asano M., Sudo K., et al. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 1998, 187:1463-1475.
74. Horai R., Saijo S., Tanioka H., et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med. 2000, 191:313-320.
75. Huang J., Gao X., Li S., Cao Z. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc. Natl. Acad. Sci. USA 1997, 94:12829-12832.
76. Huang D., Shi F.D., Giscombe R., et al. Disruption of the IL-1β gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis. Eur. J. Immunol. 2001, 31:225-232.
77. Huwiler A., Pfeilschifter J. Interleukin-1 stimulates de novo synthesis of mitogen-activated protein kinase in glomerular mesangila cells. FEBS Lett. 1994, 350:135-138.
78. Jacobs C.A., Baker P.E., Roux E.R., et al. Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor. J. Immunol. 1991, 146:2983-2989.
79. Jarrous N., Kaempfer R. Induction of human interleukin-1 gene expression by retinoic acid and its regulation at processing of precursor transcripts. J. Biol. Chem. 1994, 269:23141-23149.
80. Jiang Y., Genant H.K., Watt I., et al. A multicenter, double-blind, dose-ranging, randomized, placebo- controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum. 2000, 43:1001-1009.
81. Josephs M.D., Solorzano C.C., Taylor M., et al. Modulation of the acute phase response by altered expression of the IL-1 type 1 receptor or IL-1rα. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278:R824-R830.
82. Kaplanski G., Farnarier C., Kaplanski S., et al. Interleukin-1 induces interleukin-8 from endothelial cells by a juxacrine mechanism. Blood 1994, 84:4242-4248.
83. Kaspar R.L., Gehrke L. Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1β mRNA show unequal IL-1b protein accumulation but similar polyribosome profiles. J. Immunol. 1994, 153:277-286.
84. Kester M., Siomonson M.S., Mene P., Sedor J.R. Interleukin-1 generate transmembrane signals from phospholipids through novel pathways in cultured rat mesangial cells. J. Clin. Invest. 1989, 83:718-723.
85. Kim S.-H., Eisenstein M., Reznikov L., et al. Structural requirements of six naturally occurring isoforms of the interleukin-18 binding protein to inhibit interleukin-18. Proc. Natl Sci. USA 2000, 97:1190-1195.
86. Kim S.H., Azam T., Yoon D.Y., et al. Site-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein. Proc. Natl. Acad. Sci. USA 2001, 98:3304-3309.
87. Kim S.H., Reznikov L.L., Stuyt R.J., et al. Functional reconstitution and regulation of IL-18 activity by the IL-18R beta chain. J. Immunol. 2001, 166:148-154.
88. Koch K.-C., Ye K., Clark B.D., Dinarello C.A. Interleukin 4 (IL) 4 up-regulates gene and surface IL-1 receptor type I in murine T helper type 2 cells. Eur. J. Immunol. 1992, 22:153-157.
89. Kojima H., Takeuchi M., Ohta T., et al. Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells. Biochem. Biophys. Res. Commun. 1998, 244:183-186.
90. Kolesnick R., Golde D.W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signalling. Cell 1994, 77:325-328.
91. Kozak W., Kluger M.J., Soszynski D., et al. IL-6 and IL-1 β in fever. Studies using cytokine-deficient (knockout) mice. Ann. NY Acad. Sci. 1998, 856:33-47.
92. Kracht M., Truong O., Totty N.F., et al. Interleukin-1α activates two forms of p54a mitogen-activated proetin kinase in rabbit liver. J. Exp. Med. 1994, 180:2017-2027.
93. Kuida K., Lippke J.A., Ku G., et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1α converting enzyme. Science 1995, 267:2000-2003.
94. Kumar S., McDonnell P.C., Lehr R., et al. Identification and initial characterization of four novel members of the interleukin-1 family. J. Biol. Chem. 2000, 275:10308-10314.
95. Kuno K., Okamoto S., Hirose K., et al. Structure and function of the intracellular portion of the mouse interleukin-1 receptor (Type I). J. Biol. Chem. 1993, 268:13510-13518.
96. Kurt-Jones E.A., Beller D.I., Mizel S.B., Unanue E.R. Identification of a membrane-associated interleukin-1 in macrophages. Proc. Natl Sci. USA 1985, 82:1204-1208.
97. Labow M., Shuster D., Zetterstrom M., et al. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 1997, 159:2452-2461.
98. Lang D., Knop J., Wesche H., et al. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 respon-siveness. J. Immunol. 1998, 161:6871-6877.
99. Lee J.C., Laydon J.T., McDonnell P.C., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372:739-747.
100. Lin H., Ho A.S., Haley-Vicente D., Zhang J., et al. Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J. Biol. Chem. 2001, 276:20597-20602.
101. Lomaga M.A., Yeh W.C., Sarosi I., et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 1999, 13:1015-1024.
102. Lomedico P.T., Gubler R., Hellmann C.P., et al. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 1984, 312:458-462.
103. Lorenzo J.E., Naprta A., Rao Y., et al. Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy. Endocrinol. 1998, 139:3022-3025.
104. Maier J.A.M., Voulalas P., Roeder D., Maciag T. Extension of the life span of human endothelial cells by an interleukin-1α antisense oligomer. Science 1990, 249:1570-1574.
105. Maier J.A.M., Statuto M., Ragnotti G. Endogenous interleukin-1 α must be transported to the nucleus to exert its activity in human endothelial cells. Mol. Cell. Biol. 1994, 14:1845-1851.
106. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3K-related kinase involved in NFκβ induction by TNF, CD95 and IL-1. Nature 1997, 385:540-544.
107. Man M.Q., Wood L., Elias P.M., Feingold K.R. Cutaneous barrier repair and pathophysiology following barrier disruption in IL-1 and TNF type I receptor deficient mice. Exp. Dermatol. 1999, 8:261-266.
108. Martin M., Bol G.F., Eriksson A., et al. Interleukin-1-induced activation of a protein kinase co-precipitating with the type I interleukin-1 receptor in T-cells. Eur. J. Immunol. 1994, 24:1566-1571.
109. Martin T.J., Romas E., Gillespie M.T. Interleukins in the control of osteoclast differentiation. Crit. Rev. Eukaryot. Gene Expr. 1998, 8:107-123.
110. Mathias S., Younes A., Kan C.-C., et al. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science 1993, 259:519-522.
111. Matsushima K., Kobayashi Y., Copeland T.D., et al. Phosphorylation of a cytosolic 65-kDa protein induced by interleukin-1 in glucocorticoid pretreated normal human peripheral blood mononuclear leukocytes. J. Immunol. 1987, 139:3367-3374.
112. McMahon C.J., Slack J.L., Mosley B., et al. A novel IL-1 receptor cloned form B cells by mammalian expression is expressed in many cell types. EMBO J. 1991, 10:2821-2832.
113. Miller L.C., Isa S., Vannier E., et al. Live Borrelia burgdorferi preferentially activate IL-1b gene expression and protein synthesis over the interleukin-1 receptor antagonist. J. Clin. Invest. 1992, 90:906-912.
114. Mitchum J.L., Sims J.E. IIP1: a novel human that interacts with the IL-1 receptor. Cytokine 1995, 7:595. (Abstr.).
115. Miwa K., Asano M., Horai R., et al. Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand. Nat. Med. 1998, 4:1287-1292.
116. Mizel S.B. Cyclic AMP and interleukin-1 signal transduction. Immunol. Today 1990, 11:390-391.
117. Moritz D., Rodewald H.-R., Gheyselinck J., Klemenz R. The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells an on fetal blood mast cell progenitors. J. Immunol. 1998, 161:4866-4874.
118. Mulero J.J., Pace A.M., Nelken S.T., et al. IL1HY1: A novel interleukin-1 receptor antagonist gene. Biochem. Biophys. Res. Commun. 1999, 263:702-706.
119. Munoz E., Beutner U., Zubiaga A., Huber B.T. IL-1 activates two separate signal transduction pathways in T helper type II cells. J. Immunol. 1990, 144:964-969.
120. Nakae S., Asano M., Horai R., Iwakura Y. Interleukin-1 β, but not interleukin-1 α, is required for T-cell- dependent antibody production. Immunology 2001, 104:402-409.
121. Netea M.G., Kullberg B.J., Boerman O.C., et al. Soluble murine IL-1 receptor type I induces release of constitutive IL-1 α. J. Immunol. 1999, 162:4876-4881.
122. Neumann D., Kollewe C., Martin M.U., Boraschi D. The membrane form of the type II IL-1 receptor accounts for inhibitory function. J. Immunol. 2000, 165:3350-3357.
123. Nicklin M.J., Hughes D.E., Barton J.L., et al. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J. Exp. Med. 2000, 191:303-312.
124. Nicoletti F., Di Marco R., Barcellini W., et al. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. Eur J. Immunol. 1994, 24:1843-1847.
125. Novick D., Kim S.-H., Fantuzzi G., et al. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999, 10:127-136.
126. Novick D., Schwartsburd B., Pinkus R., et al. A novel IL-18BP ELISA shows elevated serum il-18bp in sepsis and extensive decrease of free IL-18. Cytokine 2001, 14:334-342.
127. O'Neill L.A.J. Towards and understanding of the signal transduction pathways for interleukin-1. Biochim. Biophys. Acta 1995, 1266:31-44.
128. Orencole S.F., Dinarello C.A. Characterization of a subclone (D10S) of the D10.G4.1 helper T-cell line which proliferates to attomolar concentrations of interleukin-1 in the absence of mitogens. Cytokine 1989, 1:14-22.
129. Pan G., Risser P., Mao W., et al. IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp. Cytokine 2001, 13:1-7.
130. Parnet P., Garka K.E., Bonnert T.P., et al. IL-1Rrp is a novel receptor-like molecule, similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J. Biol. Chem. 1996, 271:3967-3970.
131. Parsey M.V., Kaneko D., Shenkar R., Abraham E. Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of IL-1β. Clin. Immunol. 1999, 91:219-225.
132. Perregaux D., Barberia J., Lanzetti A.J., et al. IL-1β maturation: evidence that mature cytokine formation can be induced specifically by nigercin. J. Immunol. 1992, 149:1294-1303.
133. Perregaux D.G., Gabel C.A. Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-1 α and IL-1 β occurs via a similar mechanism. J. Immunol. 1998, 160:2469-2477.
134. Perregaux D.G., McNiff P., Laliberte R., et al. ATP acts as an agonist to promote stimulus-induced secretion of IL-1 β and IL-18 in human blood. J. Immunol. 2000, 165:4615-4623.
135. Pitti R.M., Marsters S.A., Haak-Frendscho M., et al. Molecular and biological properties of an interleukin-1 receptor immunoadhesin. Mol. Immunol. 1994, 31:1345-1351.
136. Preas H.L., Reda D., Tropea M., et al. Effects of recombinant soluble type I interleukin-1 receptor on human inflammatory responses to endotoxin. Blood 1996, 88:2465-2472.
137. Probert L., Plows D., Kontogeorgos G., Kollias G. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur. J. Immunol. 1995, 25:1794-1797.
138. Puren A.J., Fantuzzi G., Dinarello C.A. Gene expression, synthesis and secretion of IL-1β and IL-18 are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc. Natl Acad. Sci. USA 1999, 96:2256-2261.
139. Qwarnstrom E.E., Page R.C., Gillis S., Dower S.K. Binding, internalization, and intracellular localization of interleukin-1 β in human diploid fibroblasts. J. Biol. Chem. 1988, 263:8261-8269.
140. Rectenwald J.E., Moldawer L.L., Huber T.S., et al. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 2000, 102:1697-1702.
141. Reznikov L.L., Shames B.D., Barton H.A., et al. Interleukin-1β-deficiency results in reduced NFκβ levels in pregnant mice. Am. J. Physiol. 2000, 278:R263-R270.
142. Robinson D., Shibuya K., Mui A., et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-g production and activates IRAK and NFkB. Immunity 1997, 7:571-581.
143. Rosenbaum J.T., Han Y.B., Park J.M., et al. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice. J. Rheumatol. 1998, 25:2408-2416.
144. Rosoff P.M. Characterization of the interleukin-1-stimulated phospholipase C activity in human T lymphocytes. Lymphokine Res. 1989, 8:407-413.
145. Rosoff P.M., Savage N., Dinarello C.A. Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism. Cell 1988, 54:73-81.
146. Sana T.R., Debets R., Timans J.C., et al. Computational identification, cloning, and characterization of IL-1R9, a novel interleukin-1 receptor-like gene encoded over an unusually large interval of human chromosome Xq22.2-q22.3. Genomics 2000, 69:252-262.
147. Savage N., Puren A.J., Orencole S.F., et al. Studies on IL-1 receptors on D10S T-helper cells: demonstration of two molecularly and antigenically distinct IL-1 binding proteins. Cytokine 1989, 1:23-25.
148. Scapigliati G., Ghiara P., Bartalini A., et al. Differential binding of IL-1α and IL-1β to receptors on B and T cells. FEBS Lett. 1989, 243:394-398.
149. Schindler R., Clark B.D., Dinarello C.A. Dissociation between interleukin-1β mRNA and protein synthesis in human peripheral blood mononuclear cells. J. Biol. Chem. 1990, 265:10232-10237.
150. Schutze S., Machleidt T., Kronke M. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J. Leukoc. Biol. 1994, 56:533-541.
151. Seki T., Healy A.M., Fletcher D.S., et al. IL-1β mediates induction of hepatic type 1 plasminogen activator inhibitor in response to local tissue injury. Am. J. Physiol. 1999, 277:G801-G809.
152. Shapiro L., Dinarello C.A. Osmotic regulation of cytokine synthesis in vitro. Proc. Natl Sci. USA 1995, 92:12230-12234.
153. Shapiro L., Dinarello C.A. Cytokine expression during osmotic stress. Exp. Cell. Res. 1997, 231:354-362.
154. Shapiro L., Heidenreich K.A., Meintzer M.K., Dinarello C.A. Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. Proc. Natl Acad. Sci. USA 1998, 95:7422-7426.
155. Shapiro L., Puren A.J., Barton H.A., et al. Interleukin-18 stimulates HIV type 1 in monocytic cells. Proc. Natl Sci. USA 1998, 95:12550-12555.
156. Shirakawa F., Tanaka Y., Ota T., et al. Expression of interleukin-1 receptors on human peripheral T-cells. J. Immunol. 1987, 138:4243-4248.
157. Shornick L.P., De Togni P., Mariathasan S., et al. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzone. J. Exp. Med. 1996, 183:1427-1436.
158. Shornick L.P., Bisarya A.K., Chaplin D.D. IL-1β is essential for langerhans cell activation and antigen delivery to the lymph nodes during contact sensitization: evidence for a dermal source of IL-1β. Cell. Immunol. 2001, 211:105-112.
159. Sims J.E., March C.J., Cosman D., et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 1988, 241:585-589.
160. Sims J.E., Giri J.G., Dower S.K. The two interleukin-1 receptors play different roles in IL-1 activities. Clin. Immunol. Immunopathol. 1994, 72:9-14.
161. Sims J.E., Painter S.L., Gow I.R. Genomic organization of the type I and type II IL-1 receptors. Cytokine 1995, 7:483-490.
162. Smith J.W., Longo D., Alford W.G., et al. The effects of treatment with interleukin-1α on platelet recovery after high-dose carboplatin. N. Engl. J. Med. 1993, 328:756-761.
163. Solle M., Labasi J., Perregaux D.G., et al. Altered cytokine production in mice lacking P2X(7) receptors. J. Biol. Chem. 2001, 276:125-132.
164. Spriggs M.K., Hruby D.E., Maliszewski C.R., et al. Vaccinia and cowpox viruses encode a novel secreted interleukin-1 binding protein. Cell 1992, 71:145-152.
165. Stylianou E., O'Neill L.A.J., Rawlinson L., et al. Interleukin-1 induces NFkB through its type I but not type II receptor in lymphocytes. J. Biol. Chem. 1992, 267:15836-15841.
166. Stylianou E., Saklatvala J. Interleukin-1. Int. J. Biochem. Cell. Biol. 1998, 30:1075-1079.
167. Suzuki N., Suzuki S., Duncan G.S., et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002, 416:750-756.
168. Symons J.A., Eastgate J.A., Duff G.W. Purification and characterization of a novel soluble receptor for interleukin-1. J. Exp. Med. 1991, 174:1251-1254.
169. Symons J.A., Young P.A., Duff G.W. The soluble interleukin-1 receptor: ligand binding properties and mechanisms of release. Lymphokine Cytokine Res. 1993, 12:381.
170. Symons J.A., Young P.A., Duff G.W. Differential release and ligand binding of type II IL-1 receptors. Cytokine 1993, 6:555. (Abstr.).
171. Thompson G.J., Langlais C., Cain K., et al. Elevated extracellular K inhibits death-receptor and chemical-mediated apoptosis prior to caspase activation and cytochrome c release. Biochem. J. 2001, 357:137-145.
172. Tone M., Thompson S.A.J., Tone Y., et al. Regulation of IL-18 (IFN-γ-inducing factor) gene expression. J. Immunol. 1997, 159:6156-6163.
173. Torigoe K., Ushio S., Okura T., et al. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 1997, 272:25737-25742.
174. Tsutsui H., Kayagaki N., Kuida K., et al. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 1999, 11:359-367.
175. Vannier E., Dinarello C.A. Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells: comparison with IL-1 receptor antagonist. J. Clin. Invest. 1993, 92:281-287.
176. Vargas S.J., Naprta A., Glaccum M., et al. Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor. J. Bone Miner. Res. 1996, 11:1736-1744.
177. Vidal-Vanaclocha F., Fantuzzi G., Mendoza L., et al. IL-18 regulates IL-1β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc. Natl Acad. Sci. USA 2000, 97:734-739.
178. Watanabe N., Kawaguchi M., Kobayashi Y. Activation of interleukin-1β converting enzyme by nigericin is independent of apoptosis. Cytokine 1998, 10:645-653.
179. Wesche H., Korherr C., Kracht M., et al. The interleukin-1 receptor accessory protein is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J. Biol. Chem. 1997, 272:7727-7731.
180. Willenberg H.S., Stratakis C.A., Marx C., et al. Aberrent interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome. N. Engl. J. Med. 1998, 339:27-31.
181. Ye K., Koch K.-C., Clark B.D., Dinarello C.A. Interleukin-1 down regulates gene and surface expression of interleukin-1 receptor type I by destabilizing its mRNA whereas interleukin-2 increases its expression. Immunol. 1992, 75:427-434.
182. Ye K., Dinarello C.A., Clark B.D. Identification of the promoter region of the human interleukin 1 type I receptor gene: multiple initiation sites, high G+C content, and constitutive expression. Proc. Natl Sci. USA 1993, 90:2295-2299.
183. Ye K., Vannier E., Clark B.D., et al. Three distinct promoters direct transcription of different 5' untranslated regions of the human interleukin 1 type I receptor: a possible mechanism for control of translation. Cytokine 1996, 8:421-429.
184. Yoon D.Y., Dinarello C.A. Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1β activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein. J. Immunol. 1998, 160:3170-3179.
185. Zhang S., Han J., Sells M.A., et al. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J. Biol. Chem. 1995, 270:23934-23936.
186. Zheng H., Fletcher D., Kozak W., et al. Resistance to fever induction and impaired acute-phase response in interleukin-1β deficient mice. Immunity 1995, 3:9-19.